Contract Development and Manufacturing Organization Outsourcing Market Analysis North America, Europe, APAC, South America, Middle East and Africa - US, China, India, Germany, UK - Size and Forecast 2023-2027

Published: Nov 2022 Pages: 170 SKU: IRTNTR43489

The contract development and manufacturing organization (CDMO) outsourcing market is estimated to grow at a CAGR of 12.76% between 2022 and 2027. The size of the market is forecast to increase by USD 84.14 billion. The growth of the market depends on several factors, including the growing pharmaceutical industry, the increasing demand for one-stop-shop CDMOs, and the support of CDMO in reducing operational and capital expenses.

This report extensively covers market segmentation by product (small molecules and biologics), service (api/bulk drugs, drug product manufacturing, and packaging), and geography (North America, Europe, APAC, South America, and Middle East and Africa). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Contract Development And Manufacturing Organization (CDMO) Outsourcing Market During the Forecast Period?

To learn more about this report, Download Report Sample

Contract Development And Manufacturing Organization (CDMO) Outsourcing Market: Key Drivers, Trends, Challenges, and Customer Landscape

 Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Contract Development And Manufacturing Organization (CDMO) Outsourcing Market Driver

The growing pharmaceutical industry will fuel the growth of the contract development and manufacturing organization outsourcing market. To cater to the high-volume demand for pharmaceuticals, pharma and biotech enterprises require sufficient manufacturing capabilities to produce the expected quantity and meet the quality levels at controlled costs. Some of the small pharma and biotech enterprises cannot cater to the demand growth from their existing facilities, and they do not have enough funds to invest in the expansion of their manufacturing facilities. 

The small enterprises outsource some of the processes to CDMOs as it will help them to cater to the growing demand in the market. Such factors will help enterprises to manufacture a large number of drugs or medicines in a short period, which, in turn, will drive the growth of the global CDMO outsourcing market during the forecast period. 

Significant Contract Development And Manufacturing Organization (CDMO) Outsourcing Market Trends

Growing use of analytics by CDMOs is the primary trend for the contract development and manufacturing organization outsourcing market growth. There are many analytical tools and techniques that can be used by CDMOs. The use of analytics by CDMOs will aid enterprises to enhance productivity and efficiency by discovering meaningful patterns in the data using forecast analytics, charts, percentage change analytics, and numerical analytics. The use of analytics by CDMOs can be a complex process as it needs to be executed in real-time and in a dynamic framework.

This solution also helps CDMOs to develop and utilize methods that can make the development process of a product more efficient. Various CDMOs are using analytics to offer their customers better solutions. The growing use of analytics by CDMOs will lead to the growth of the global CDMO market during the forecast period. 

Major Contract Development And Manufacturing Organization (CDMO) Outsourcing Market Challenge

Threat of infringement of intellectual property (IP) rights is one of the key challenges hindering the CDMO market growth. Developing a new drug or medicine and successfully launching it in the market is a lengthy and expensive process. Hence, they strongly protect their IP such as patents of drugs or medicines across the globe until they expire. Enterprises outsource the manufacturing of patented drugs or medicines to CDMOs to speed up the production process and make the patented product available in the market quickly before the IP rights expire. This will help them to gain market share and get the maximum return on investment before patent expiry. Outsourcing can cause a threat to its IP.

CDMOs might not have an appropriate strategy for preserving and protecting critical IPs, which can cause the infringement of the IP rights of the drug or medicine. The infringement of the IP rights of the drug or medicine can impact the trust of pharma and biotech enterprises over CDMOs, which, in turn, can impact the growth of the global CDMO market during the forecast period.

Key Contract Development And Manufacturing Organization (CDMO) Outsourcing Market Customer Landscape

The report includes the adoption lifecycle of the CDMO market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Customer Landscape

Who are the Major Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the CDMO market.

Alcaminow - The company offers a broad range of pharma manufacturing facilities. Also, Under this segment, the company offers complete contract development, testing, and manufacturing services to pharma and biotech companies

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Celonic AG
  • Corden Pharma International GmbH
  • Eurofins Scientific SE
  • FAMAR Health Care Services
  • FUJIFILM Holdings Corp
  • Lonza Group Ltd.
  • Piramal Enterprises Ltd.
  • Recipharm AB
  • Siegfried Holding AG
  • The Lubrizol Corp.
  • Thermo Fisher Scientific Inc.
  • Aenova Holding GmbH

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key CDMO market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Contract Development And Manufacturing Organization (CDMO) Outsourcing Market?

The market share growth by the small molecules segment will be significant during the forecast period. Small molecules are naturally occurring compounds that have been re-synthesized or isolated in laboratories. Most of these small molecules are independent of the manufacturing process. They can be formulated into orally delivered doses that offer better compliance and involve lower costs than injectables. They have the ability to reach almost any desired destination inside the body, owing to their small size. Also, their small structure helps them to penetrate cell membranes easily, which makes them more effective in some cases. Owing to these benefits, the demand for small molecules is expected to grow exponentially during the forecast period.

Get a glance at the market contribution of various segments Request a PDF Sample

The small molecules segment was valued at USD 48.14 billion in 2017 and continue to grow by 2021Furthermore, due to the increasing demand for small molecules, various CDMOs are investing in expanding their facilities to cater to the large market or are acquiring new vendors to enhance their product offerings. For instance, in May 2021, Enteris BioPharma Inc. announced the expansion of its Boonton, NJ manufacturing facility and the launch of its CDMO business segment. This was aimed to provide custom solutions for the formulation, development, and manufacturing of solid oral doses, as it is difficult to formulate BCS III and IV compounds, including peptides and highly potent compounds. All these factors are expected to increase the demand for small molecules, which, in turn, will lead to the growth of the global CDMO market during the forecast period.

Which are the Key Regions for the Contract Development And Manufacturing Organization (CDMO) Outsourcing Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The CDMO outsourcing market in North America is expected to grow due to the increase in the number of people with chronic diseases in countries such as the US and Canada. Poor lifestyle choices, such as the overconsumption of alcohol, smoking, lack of physical activity, poor diet, and inadequate relief from chronic stress are some of the reasons for the rise in the number of people with chronic disease. These factors lead to the development and progression of chronic diseases, such as Type 2 diabetes, obesity, hypertension, and cardiovascular diseases. This, in turn, will lead to the growth of the CDMO outsourcing market in North America during the forecast period.

This report forecasts the contribution of all the segments to the growth of the CDMO market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. COVID-19 led to an upsurge in the demand for North America.  In 2021, mass vaccination drives and other government initiatives resulted in the relaxation of lockdown restrictions and the resumption of business operations. Moreover, with the advent of COVID-19 vaccines, primarily in the US and Canada, business operations resumed, and the market in focus in North America is expected to recover during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook (USD Billion, 2017 - 2027)
    • Small molecules
    • Biologics
  • Service Outlook (USD Billion, 2017 - 2027)
    • API/bulk drugs
    • Drug product manufacturing
    • Packaging
  • Region Outlook (USD Billion, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • South America
      • Chile
      • Argentina
      • Brazil
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Contract Development And Manufacturing Organization (CDMO) Outsourcing Market Scope

Report Coverage

Details

Page number

170

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.76%

Market growth 2023-2027

USD 84.14 billion

Market structure

Concentrated

YoY growth 2022-2023(%)

12.15

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 33%

Key countries

US, China, India, Germany, and UK

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Alcami Corp., Almac Group Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., Celonic AG, Corden Pharma International GmbH, Eurofins Scientific SE, FAMAR Health Care Services, FUJIFILM Holdings Corp, Lonza Group Ltd., Piramal Enterprises Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., Thermo Fisher Scientific Inc., Aenova Holding GmbH, Curia Inc., Laboratory Corp. of America Holdings, NextPharma GmbH, and Vetter Pharma-Fertigung GmbH & Co. KG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Contract Development And Manufacturing Organization (CDMO) Outsourcing Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the CDMO Market between 2023 and 2027
  • Precise estimation of the size of the contract development and manufacturing organization (CDMO) outsourcing market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, APAC, South America, and Middle East and Africa
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of contract development and manufacturing organization (CDMO) outsourcing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Service
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global contract development and manufacturing organization (CDMO) outsourcing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global contract development and manufacturing organization (CDMO) outsourcing market 2017 - 2021 ($ billion)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
    • 4.3 Services Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Services Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Small molecules - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Small molecules - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Small molecules - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
    • 6.4 Biologics - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Biologics - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ billion)

    7 Market Segmentation by Service

    • 7.1 Market segments
      • Exhibit 43: Chart on Service - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Service - Market share 2022-2027 (%)
    • 7.2 Comparison by Service
      • Exhibit 45: Chart on Comparison by Service
      • Exhibit 46: Data Table on Comparison by Service
    • 7.3 API/bulk drugs - Market size and forecast 2022-2027
      • Exhibit 47: Chart on API/bulk drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 48: Data Table on API/bulk drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Chart on API/bulk drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on API/bulk drugs - Year-over-year growth 2022-2027 (%)
    • 7.4 Drug product manufacturing - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Drug product manufacturing - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 52: Data Table on Drug product manufacturing - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Chart on Drug product manufacturing - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Drug product manufacturing - Year-over-year growth 2022-2027 (%)
    • 7.5 Packaging - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Packaging - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 56: Data Table on Packaging - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Chart on Packaging - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Packaging - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Service
      • Exhibit 59: Market opportunity by Service ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 APAC - Market size and forecast 2022-2027
      • Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
    • 9.6 South America - Market size and forecast 2022-2027
      • Exhibit 77: Chart on South America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 78: Data Table on South America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 79: Chart on South America - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on South America - Year-over-year growth 2022-2027 (%)
    • 9.7 Middle East and Africa - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 82: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 83: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • 9.8 US - Market size and forecast 2022-2027
      • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Germany - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.12 India - Market size and forecast 2022-2027
      • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 105: Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 108: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 109: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 110: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 111: Matrix on vendor position and classification
            • 12.3 Aenova Holding GmbH
              • Exhibit 112: Aenova Holding GmbH - Overview
              • Exhibit 113: Aenova Holding GmbH - Product / Service
              • Exhibit 114: Aenova Holding GmbH - Key offerings
            • 12.4 Alcami Corp.
              • Exhibit 115: Alcami Corp. - Overview
              • Exhibit 116: Alcami Corp. - Product / Service
              • Exhibit 117: Alcami Corp. - Key offerings
            • 12.5 Almac Group Ltd.
              • Exhibit 118: Almac Group Ltd. - Overview
              • Exhibit 119: Almac Group Ltd. - Product / Service
              • Exhibit 120: Almac Group Ltd. - Key offerings
            • 12.6 Boehringer Ingelheim International GmbH
              • Exhibit 121: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 122: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 123: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 124: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 125: Boehringer Ingelheim International GmbH - Segment focus
            • 12.7 Catalent Inc.
              • Exhibit 126: Catalent Inc. - Overview
              • Exhibit 127: Catalent Inc. - Business segments
              • Exhibit 128: Catalent Inc. - Key news
              • Exhibit 129: Catalent Inc. - Key offerings
              • Exhibit 130: Catalent Inc. - Segment focus
            • 12.8 Celonic AG
              • Exhibit 131: Celonic AG - Overview
              • Exhibit 132: Celonic AG - Product / Service
              • Exhibit 133: Celonic AG - Key offerings
            • 12.9 Corden Pharma International GmbH
              • Exhibit 134: Corden Pharma International GmbH - Overview
              • Exhibit 135: Corden Pharma International GmbH - Product / Service
              • Exhibit 136: Corden Pharma International GmbH - Key offerings
            • 12.10 Curia Inc.
              • Exhibit 137: Curia Inc. - Overview
              • Exhibit 138: Curia Inc. - Product / Service
              • Exhibit 139: Curia Inc. - Key news
              • Exhibit 140: Curia Inc. - Key offerings
            • 12.11 Eurofins Scientific SE
              • Exhibit 141: Eurofins Scientific SE - Overview
              • Exhibit 142: Eurofins Scientific SE - Business segments
              • Exhibit 143: Eurofins Scientific SE - Key news
              • Exhibit 144: Eurofins Scientific SE - Key offerings
              • Exhibit 145: Eurofins Scientific SE - Segment focus
            • 12.12 FAMAR Health Care Services
              • Exhibit 146: FAMAR Health Care Services - Overview
              • Exhibit 147: FAMAR Health Care Services - Product / Service
              • Exhibit 148: FAMAR Health Care Services - Key offerings
            • 12.13 FUJIFILM Holdings Corp
              • Exhibit 149: FUJIFILM Holdings Corp - Overview
              • Exhibit 150: FUJIFILM Holdings Corp - Business segments
              • Exhibit 151: FUJIFILM Holdings Corp - Key offerings
              • Exhibit 152: FUJIFILM Holdings Corp - Segment focus
            • 12.14 Lonza Group Ltd.
              • Exhibit 153: Lonza Group Ltd. - Overview
              • Exhibit 154: Lonza Group Ltd. - Business segments
              • Exhibit 155: Lonza Group Ltd. - Key news
              • Exhibit 156: Lonza Group Ltd. - Key offerings
              • Exhibit 157: Lonza Group Ltd. - Segment focus
            • 12.15 Piramal Enterprises Ltd.
              • Exhibit 158: Piramal Enterprises Ltd. - Overview
              • Exhibit 159: Piramal Enterprises Ltd. - Business segments
              • Exhibit 160: Piramal Enterprises Ltd. - Key offerings
              • Exhibit 161: Piramal Enterprises Ltd. - Segment focus
            • 12.16 Recipharm AB
              • Exhibit 162: Recipharm AB - Overview
              • Exhibit 163: Recipharm AB - Business segments
              • Exhibit 164: Recipharm AB - Key offerings
              • Exhibit 165: Recipharm AB - Segment focus
            • 12.17 Siegfried Holding AG
              • Exhibit 166: Siegfried Holding AG - Overview
              • Exhibit 167: Siegfried Holding AG - Business segments
              • Exhibit 168: Siegfried Holding AG - Key offerings
              • Exhibit 169: Siegfried Holding AG - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 170: Inclusions checklist
                • Exhibit 171: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 172: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 173: Research methodology
                • Exhibit 174: Validation techniques employed for market sizing
                • Exhibit 175: Information sources
              • 13.5 List of abbreviations
                • Exhibit 176: List of abbreviations

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                PURCHASE FULL REPORT OF

                contract development and manufacturing organization (cdmo) outsourcing market market

                Key Questions Answered

                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?

                Why should you prefer Technavio's market insights report?

                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis